News | Enterprise Imaging | April 05, 2019

Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium

In-viewer workflow, work-in-progress artificial intelligence among features on display

Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium

April 5, 2019 — Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla.

Key elements of the Visage 7 platform that will be on display include:

  • All images in one viewer. Users can eliminate dedicated breast imaging workstations and siloed breast imaging archives with a single enterprise imaging platform for every user, providing access to all diagnostic imaging modalities and multimedia content via the same Visage 7 smart-client.
  • Comprehensive, ultrafast performance. Server-side processing provides access to all of the imaging needed to immediately interpret today’s digital breast tomosynthesis (DBT) exams, and all prior exams, in less than 3 seconds, according to Visage Imaging.
  • In-viewer workflow. Visage 7 users have access to the entire patient jacket, and use step-based protocols to display all prior multimodality breast imaging. Many Visage customers routinely display 10-plus years of priors, including DBT (as well as high-resolution DBT and projection images, too), breast magnetic resonance (MR), and breast ultrasound.
  • Future proof and Visage 7 AI. Breast imaging study sizes keep growing, with molecular breast imaging and high-resolution DBT today, and opto-acoustic breast ultrasound on the horizon. Furthermore, Visage will demonstrate its work-in-progress platform approach to artificial intelligence (AI), Visage 7 AI, with integration to native and third-party algorithms.

For more information: www.visageimaging.com

Related Content

Graphic courtesy of Pixabay

Graphic courtesy of Pixabay

Feature | Artificial Intelligence | April 22, 2019 | By Greg Freiherr
...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...